← All research updates

Radiation may help a vaccine wake up the immune system in brain tumors

Original title: Radiation therapy synergizes with mRNA vaccination to overcome microglia-mediated suppression of dendritic cell migration and T cell priming in glioblastoma

How far along is this research?

This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.

This is early lab research, not yet tested in people.

The short version

Early lab work suggests radiation and an mRNA vaccine may work better together against glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary.

What was studied. Researchers studied immune cells called dendritic cells in glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary, a brain tumor. These cells help the body spot a tumor and attack it. The team tested a drug that blocks a signal called AXL, and radiation given with an mRNA vaccine.

What they found. The tumors held mostly the wrong kind of dendritic cell, and those cells were poor at showing the tumor to the immune system. Brain cells called microglia sent signals that kept dendritic cells from traveling to nearby lymph nodes. Blocking that signal let the cells travel again and helped the immune attack. Radiation plus the mRNA vaccine made tumors go away fully, and the effect lasted.

What this means, and what it doesn't

What it could mean: This points to a reason the immune system often fails against glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary. It also suggests a path worth testing, giving radiation and a vaccine together. For now it is a clue for researchers, not a treatment choice you can make with your doctor.

What it doesn't mean: This does not mean a new treatment is ready. The work is early lab research, far from everyday care. It is not proof that this helps people, and it is not a cure. No one should change their care based on this.

Source: bioRxiv (preprint), September 22, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary